• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从血液测量推断抗 HIV 分子替诺福韦的黏膜药代动力学和药效学。

Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood.

机构信息

Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA.

Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina, USA.

出版信息

Sci Rep. 2019 Jan 14;9(1):82. doi: 10.1038/s41598-018-36004-z.

DOI:10.1038/s41598-018-36004-z
PMID:30643165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6331591/
Abstract

Microbicide pharmacokinetic (PK) studies typically sample drug in luminal fluid, mucosal tissue, and blood. Blood measurements can be conducted most frequently, serially within subjects. Antiretroviral drugs, however, act against HIV in mucosal tissue/cells. We computationally modeled the extent measurements in blood can predict concentrations in tissue, focusing on the antiretroviral drug tenofovir delivered by a vaginal gel. Deterministic PK models input host and product factors and output spatiotemporal drug concentrations in luminal fluid, epithelium, stroma/host cells, and blood. Pharmacodynamic (PD) analysis referenced stroma/host cell concentrations to prophylactic values; summary metrics were time from product insertion to protection (t) and degree of protection (PP). Results incorporated host factors characteristic of population variability. Neural nets (NN) linked simulated blood PK metrics (C, t, AUC, C) to mucosal PK/PD metrics. The NNs delivered high-performance mapping of these multiparametric relationships. Given multi-log variability typical of biopsy data for tenofovir and other topical microbicides, results suggest downstream but higher fidelity measurements in blood could help improve determination of PK and create inferences about PD. Analysis here is for a tenofovir gel, but this approach offers promise for application to other microbicide modalities and to topical drug delivery to vaginal mucosa more generally.

摘要

杀微生物剂药代动力学(PK)研究通常在腔液、黏膜组织和血液中采样药物。可以最频繁地在受试者中进行血液测量,连续进行。然而,抗逆转录病毒药物在黏膜组织/细胞中对抗 HIV。我们通过计算模型来预测组织中的浓度,重点是阴道凝胶中递送的抗逆转录病毒药物替诺福韦。确定性 PK 模型输入宿主和产品因素,并输出腔液、上皮、基质/宿主细胞和血液中的时空药物浓度。药效学(PD)分析参考基质/宿主细胞浓度以达到预防值;总结指标是从产品插入到保护的时间(t)和保护程度(PP)。结果纳入了具有人群变异性特征的宿主因素。神经网络(NN)将模拟的血液 PK 指标(C、t、AUC、C)与黏膜 PK/PD 指标联系起来。NN 提供了这些多参数关系的高性能映射。鉴于替诺福韦和其他局部杀微生物剂活检数据的多对数变异性,结果表明血液中的下游但更保真度测量可以帮助确定 PK 并推断 PD。这里的分析适用于替诺福韦凝胶,但这种方法有望应用于其他杀微生物剂模式和更一般地应用于阴道黏膜的局部药物输送。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/7a6143d59b0a/41598_2018_36004_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/b5eb084b6d47/41598_2018_36004_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/619a1aa08298/41598_2018_36004_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/2a2a92f9a8c9/41598_2018_36004_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/29995eaf5a8c/41598_2018_36004_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/0de94329e692/41598_2018_36004_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/7a6143d59b0a/41598_2018_36004_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/b5eb084b6d47/41598_2018_36004_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/619a1aa08298/41598_2018_36004_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/2a2a92f9a8c9/41598_2018_36004_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/29995eaf5a8c/41598_2018_36004_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/0de94329e692/41598_2018_36004_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4c0/6331591/7a6143d59b0a/41598_2018_36004_Fig6_HTML.jpg

相似文献

1
Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood.从血液测量推断抗 HIV 分子替诺福韦的黏膜药代动力学和药效学。
Sci Rep. 2019 Jan 14;9(1):82. doi: 10.1038/s41598-018-36004-z.
2
Sensitivity Analysis of a Pharmacokinetic Model of Vaginal Anti-HIV Microbicide Drug Delivery.阴道抗HIV杀微生物剂药物递送药代动力学模型的敏感性分析
J Pharm Sci. 2016 May;105(5):1772-1778. doi: 10.1016/j.xphs.2016.02.015. Epub 2016 Mar 22.
3
Vaginal deployment and tenofovir delivery by microbicide gels.通过杀微生物剂凝胶进行阴道给药和替诺福韦递送。
Drug Deliv Transl Res. 2015 Jun;5(3):279-94. doi: 10.1007/s13346-015-0227-1.
4
Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs.载药纳米粒子薄膜用于联合阴道递抗 HIV 微生态制剂
J Control Release. 2016 Dec 10;243:43-53. doi: 10.1016/j.jconrel.2016.09.020. Epub 2016 Sep 21.
5
Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.通过设计用于预防 HIV-1 的 pod-intravaginal 环来输送单一、双重和三重抗逆转录病毒药物配方的安全性和药代动力学:一项 I 期试验。
PLoS Med. 2018 Sep 28;15(9):e1002655. doi: 10.1371/journal.pmed.1002655. eCollection 2018 Sep.
6
Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.载有替诺福韦的纳米颗粒薄膜作为新型阴道杀微生物剂递送系统的研发及体内安全性评估。
Acta Biomater. 2016 Oct 15;44:332-40. doi: 10.1016/j.actbio.2016.08.018. Epub 2016 Aug 17.
7
A Phase 1 Randomized, Blinded Comparison of the Pharmacokinetics and Colonic Distribution of Three Candidate Rectal Microbicide Formulations of Tenofovir 1% Gel with Simulated Unprotected Sex (CHARM-02).一项关于三种候选替诺福韦1%凝胶直肠微杀菌剂制剂在模拟无保护性行为下的药代动力学和结肠分布的1期随机、盲法比较研究(CHARM-02)。
AIDS Res Hum Retroviruses. 2015 Nov;31(11):1098-108. doi: 10.1089/AID.2015.0098. Epub 2015 Aug 24.
8
Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography.使用共配准的共聚焦拉曼光谱和光学相干断层扫描对替诺福韦向阴道组织的递送进行无标记分析。
PLoS One. 2017 Sep 29;12(9):e0185633. doi: 10.1371/journal.pone.0185633. eCollection 2017.
9
Multicompartmental Pharmacokinetic Model of Tenofovir Delivery to the Rectal Mucosa by an Enema.通过灌肠将替诺福韦递送至直肠黏膜的多房室药代动力学模型。
PLoS One. 2017 Jan 23;12(1):e0167696. doi: 10.1371/journal.pone.0167696. eCollection 2017.
10
Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.凝胶体积对 DuoGel-IQB4012(一种双室双药 HIV 杀微生物剂凝胶)阴道和直肠应用于长尾猕猴的药代动力学的影响。
Drug Deliv Transl Res. 2018 Oct;8(5):1180-1190. doi: 10.1007/s13346-018-0538-0.

引用本文的文献

1
Modeling HIV Pre-Exposure Prophylaxis.艾滋病毒暴露前预防建模
Front Pharmacol. 2020 Jan 31;10:1514. doi: 10.3389/fphar.2019.01514. eCollection 2019.

本文引用的文献

1
Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.凝胶体积对 DuoGel-IQB4012(一种双室双药 HIV 杀微生物剂凝胶)阴道和直肠应用于长尾猕猴的药代动力学的影响。
Drug Deliv Transl Res. 2018 Oct;8(5):1180-1190. doi: 10.1007/s13346-018-0538-0.
2
Treatment and prevention of HIV infection with long-acting antiretrovirals.长效抗逆转录病毒治疗和预防 HIV 感染。
Expert Rev Clin Pharmacol. 2018 May;11(5):507-517. doi: 10.1080/17512433.2018.1453805. Epub 2018 Mar 29.
3
Assessing linkage to and retention in care among HIV patients in Uganda and identifying opportunities for health systems strengthening: a descriptive study.
评估乌干达 HIV 患者的关联和保留在护理中的情况,并确定加强卫生系统的机会:一项描述性研究。
BMC Infect Dis. 2018 Mar 23;18(1):138. doi: 10.1186/s12879-018-3042-8.
4
Factors impacting antiretroviral therapy adherence among human immunodeficiency virus-positive adolescents in Sub-Saharan Africa: a systematic review.撒哈拉以南非洲地区人类免疫缺陷病毒阳性青少年抗逆转录病毒治疗依从性的影响因素:系统评价。
Public Health. 2018 Apr;157:20-31. doi: 10.1016/j.puhe.2017.12.010. Epub 2018 Mar 20.
5
Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography.使用共配准的共聚焦拉曼光谱和光学相干断层扫描对替诺福韦向阴道组织的递送进行无标记分析。
PLoS One. 2017 Sep 29;12(9):e0185633. doi: 10.1371/journal.pone.0185633. eCollection 2017.
6
Mucosal stromal fibroblasts markedly enhance HIV infection of CD4+ T cells.黏膜基质成纤维细胞显著增强HIV对CD4+ T细胞的感染。
PLoS Pathog. 2017 Feb 16;13(2):e1006163. doi: 10.1371/journal.ppat.1006163. eCollection 2017 Feb.
7
Multicompartmental Pharmacokinetic Model of Tenofovir Delivery to the Rectal Mucosa by an Enema.通过灌肠将替诺福韦递送至直肠黏膜的多房室药代动力学模型。
PLoS One. 2017 Jan 23;12(1):e0167696. doi: 10.1371/journal.pone.0167696. eCollection 2017.
8
Coupled gel spreading and diffusive transport models describing microbicidal drug delivery.描述杀菌药物递送的耦合凝胶扩散和扩散传输模型。
Chem Eng Sci. 2016 Oct 2;152:12-20. doi: 10.1016/j.ces.2016.05.015. Epub 2016 May 12.
9
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.使用含达匹韦林的阴道环预防女性感染HIV-1。
N Engl J Med. 2016 Dec 1;375(22):2121-2132. doi: 10.1056/NEJMoa1506110. Epub 2016 Feb 22.
10
Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.基于替诺福韦的口服暴露前预防可预防女性感染艾滋病毒。
Curr Opin HIV AIDS. 2016 Jan;11(1):18-26. doi: 10.1097/COH.0000000000000207.